does compounded tirzepatide expire GLP-1 Safety: FDA Rules on Semaglutide & | Vitercure Pharmacy What is compounded tirzepatide? |

The FDA is requiring the manufacturer perform the following research even though the drug has been approved and is now available: While the medical community welcomes these new advances in prescriptions to treat obesity and overweight, it cannot be emphasized enough that CONTRAVE and other drugs are to be used only at the discretion of a trained professional

On average, tirzepatide led to 20.2% weight loss compared to 13.7% with semaglutide over 72 weeks of treatment

Notably, no serious adverse drug reactions were reported

Muscle tissue burns more calories at rest than fat, so losing muscle mass can slow your metabolic rate and make long-term weight maintenance harder after treatment ends

you're introducing a cocktail of minerals, chemicals, and unknown particulates that can degrade the fragile peptide chains and render your expensive research material useless